Stimulant

The opioid epidemic has been one of the most pressing and challenging issues that the U.S. has faced in recent decades, with countless lives lost to this devastating crisis. Now, stimulant-related overdoses are among the next big drug-related concerns, with recent studies showing that the mortality rate linked to stimulant use in the U.S. has […]

So, imagine there’s a runaway epidemic of overdose deaths that involve non-opioid drugs and that we’ve had an evidence-based therapy for this unique addiction for the last forty years—but for reasons largely grounded in legislators’ and the public’s visceral disdain for people who use substances, we have refused to nationally recognize or widely implement this […]

On January 19th, 2024, CHERISH and the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI), co-hosted a virtual convening titled Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management. Contingency management is a proven and promising treatment for specific substance use disorders, especially stimulant use disorder. However, significant gaps in knowledge regarding the […]

Stimulants are involved in a substantial and growing percentage of the more than 100,000 overdose deaths in the United States each year. Methamphetamine and cocaine are increasingly present in overdoses involving fentanyl—fueling what has been called the “fourth wave” of the opioid overdose crisis. Unlike opioid use disorder, there are no FDA-approved medications to treat […]

During the peak hour of a July summer day, CHERISH colleagues and interns from Boston Medical Center logged onto Zoom while investigators and staff in New York City filled a conference room located on the Upper East Side at Weill Cornell Medicine. Three minutes past twelve, Caroline Savitsky, program manager in the Section of Infectious […]

Meet the ninth cohort of early-career investigators from the states of California, Texas, and Washington. CHERISH awarded each investigator up to $20,000 for a pilot study that focuses on conducting health economics research in substance use, hepatitis C virus (HCV), and HIV. This year, CHERISH also encouraged applicants to integrate drug overdose prevention, the syndemics […]

The United States has made important strides to reduce the incidence and negative outcomes of HIV, including increasing the availability of effective treatment and prevention in the form of pre-exposure prophylaxis (PrEP). While the incidence of new HIV infections fell significantly from 130,000 in 1985, progress has stalled at approximately 39,000 new infections per year […]

Shoshana Aronowitz, PhD, MSHP, FNP-BC Follow Shoshana Aronowitz, PhD, MSHP, FNP-BC, on Twitter @shoshiaronowitz. Shoshana Aronowitz is a family nurse practitioner, community-engaged health services researcher, and assistant professor in the Department of Family and Community Health at the University of Pennsylvania School of Nursing. Her research examines innovative delivery models to promote equitable access to substance […]

“Dr. Kathryn McCollister’s input strengthened our application and we look forward to collaborating on this important and timely project that will provide valuable information on both the effectiveness and cost of this mHealth intervention.” Dr. Adam Carrico Approximately 1.6 million US adults used methamphetamine each year from 2015 to 2018, many of whom had co-occurring […]